COMP <GO>
CON vs JNJ // ENTERPRISE SCALE & MARKET CAP
Concentra Group Holdings Parent Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CON 6
— JNJ 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $40.38 (-2.11%) • MKT CAP: $5.26B
market-cap
$5.26B
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CON VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CON | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 25.50% | -5.80 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.4x | 18.5x | -3.10 | CON | /valuation <GO> |
| Free Cash Flow Yield | 3.75% | 2.97% | +0.78 | CON | /fcf-yield <GO> |
| Operating Margin | 15.40% | 34.70% | -19.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 28.50% | -20.80 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 13.90% | 6.00% | +7.90 | CON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.61% | 0.00% | +0.61 | CON | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.53 | 5.59 | -3.06 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.20% | -0.30 | CON | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.8 | 60.4 | +5.47 | CON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 1.08 | -0.08 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 23.0x | +3.50 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.26B | $662.49B | -$657.23B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CON REV | JNJ REV | CON GROSS % | JNJ GROSS % | CON FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.16B | $94.19B | 44.0% | 67.9% | $197.1M | $19.70B |
| FY 2024 | $1.90B | $88.82B | 44.0% | 69.1% | $210.3M | $19.84B |
| FY 2023 | $1.84B | $85.16B | 44.0% | 44.0% | $151.6M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CON // BETA 1.00
JNJ // BETA 1.08